Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

The use of genome sequencing to investigate an outbreak of hospital-acquired mucormycosis in transplant patients.

Marek C, Croxen MA, Dingle TC, Bharat A, Schwartz IS, Wiens R, Smith S.

Transpl Infect Dis. 2019 Aug 31:e13163. doi: 10.1111/tid.13163. [Epub ahead of print]

PMID:
31472083
2.

Mycobacterium chimaera encephalitis post-cardiac surgery: A new syndrome.

Lau D, Cooper R, Chen J, Sim VL, McCombe JA, Tyrrell GJ, Bhargava R, Adam B, Chapman E, Croxen MA, Garady C, Antonation K, van Landeghem FKH, Ip S, Saxinger L.

Clin Infect Dis. 2019 Jun 18. pii: ciz497. doi: 10.1093/cid/ciz497. [Epub ahead of print]

PMID:
31247065
3.

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic.

Skowronski DM, Leir S, De Serres G, Murti M, Dickinson JA, Winter AL, Olsha R, Croxen MA, Drews SJ, Charest H, Martineau C, Sabaiduc S, Bastien N, Li Y, Petric M, Jassem A, Krajden M, Gubbay JB.

Euro Surveill. 2019 Apr;24(15). doi: 10.2807/1560-7917.ES.2019.24.15.1900104.

4.

The Cutaneous Microbiome: Implications for Dermatology Practice.

Sander MA, Sander MS, Isaac-Renton JL, Croxen MA.

J Cutan Med Surg. 2019 Jul/Aug;23(4):436-441. doi: 10.1177/1203475419839939. Epub 2019 Apr 2.

PMID:
30938174
5.

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.

Skowronski DM, Leir S, Sabaiduc S, Murti M, Dickinson JA, Olsha R, Gubbay JB, Croxen MA, Charest H, Chan T, Bastien N, Li Y, Krajden M, De Serres G.

Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1900055.

6.

Human Activity Determines the Presence of Integron-Associated and Antibiotic Resistance Genes in Southwestern British Columbia.

Uyaguari-Díaz MI, Croxen MA, Luo Z, Cronin KI, Chan M, Baticados WN, Nesbitt MJ, Li S, Miller KM, Dooley D, Hsiao W, Isaac-Renton JL, Tang P, Prystajecky N.

Front Microbiol. 2018 May 1;9:852. doi: 10.3389/fmicb.2018.00852. eCollection 2018.

7.

Use of genomics to design a diagnostic assay to discriminate between Streptococcus pneumoniae and Streptococcus pseudopneumoniae.

Croxen MA, Lee TD, Azana R, Hoang LM.

Microb Genom. 2018 Jul;4(7). doi: 10.1099/mgen.0.000175. Epub 2018 Apr 9.

8.

Multi-provincial Salmonellosis Outbreak Related to Newly Hatched Chicks and Poults: A Genomics Perspective.

Croxen MA, Macdonald KA, Walker M, deWith N, Zabek E Rmccm, Peterson C, Reimer A, Chui L, Tschetter L, Hoang L, King RK.

PLoS Curr. 2017 Aug 9;9. pii: ecurrents.outbreaks.309af53b9edcc785163539c30c3953f6. doi: 10.1371/currents.outbreaks.309af53b9edcc785163539c30c3953f6.

9.

Infection control in the new age of genomic epidemiology.

Tang P, Croxen MA, Hasan MR, Hsiao WW, Hoang LM.

Am J Infect Control. 2017 Feb 1;45(2):170-179. doi: 10.1016/j.ajic.2016.05.015. Review.

10.

Pooled Nucleic Acid Amplification Test for Screening of Stool Specimens for Shiga Toxin-Producing Escherichia coli.

Jassem AN, Chou FY, Yang C, Croxen MA, Pintar KD, Paccagnella A, Hoang L, Prystajecky N.

J Clin Microbiol. 2016 Nov;54(11):2711-2715. Epub 2016 Aug 24.

11.

mcr-1-Positive Colistin-Resistant Escherichia coli in Traveler Returning to Canada from China.

Payne M, Croxen MA, Lee TD, Mayson B, Champagne S, Leung V, Bariso S, Hoang L, Lowe C.

Emerg Infect Dis. 2016 Sep;22(9):1673-5. doi: 10.3201/eid2209.160177. No abstract available.

12.

A comprehensive method for amplicon-based and metagenomic characterization of viruses, bacteria, and eukaryotes in freshwater samples.

Uyaguari-Diaz MI, Chan M, Chaban BL, Croxen MA, Finke JF, Hill JE, Peabody MA, Van Rossum T, Suttle CA, Brinkman FS, Isaac-Renton J, Prystajecky NA, Tang P.

Microbiome. 2016 Jul 19;4(1):20. doi: 10.1186/s40168-016-0166-1.

13.

Small Intestine Early Innate Immunity Response during Intestinal Colonization by Escherichia coli Depends on Its Extra-Intestinal Virulence Status.

Tourret J, Willing BP, Croxen MA, Dufour N, Dion S, Wachtel S, Denamur E, Finlay BB.

PLoS One. 2016 Apr 20;11(4):e0153034. doi: 10.1371/journal.pone.0153034. eCollection 2016.

14.

Quantitative Mass Spectrometry Identifies Novel Host Binding Partners for Pathogenic Escherichia coli Type III Secretion System Effectors.

Law RJ, Law HT, Scurll JM, Scholz R, Santos AS, Shames SR, Deng W, Croxen MA, Li Y, de Hoog CL, van der Heijden J, Foster LJ, Guttman JA, Finlay BB.

J Proteome Res. 2016 May 6;15(5):1613-22. doi: 10.1021/acs.jproteome.6b00074. Epub 2016 Mar 28.

PMID:
27018634
15.

Epidemiologic and Genotypic Review of Carbapenemase-Producing Organisms in British Columbia, Canada, between 2008 and 2014.

Sekirov I, Croxen MA, Ng C, Azana R, Chang Y, Mataseje L, Boyd D, Mangat C, Mack B, Tadros M, Brodkin E, Kibsey P, Stefanovic A, Champagne S, Mulvey MR, Hoang LM.

J Clin Microbiol. 2016 Feb;54(2):317-27. doi: 10.1128/JCM.02289-15. Epub 2015 Nov 25.

16.

Automated Gel Size Selection to Improve the Quality of Next-generation Sequencing Libraries Prepared from Environmental Water Samples.

Uyaguari-Diaz MI, Slobodan JR, Nesbitt MJ, Croxen MA, Isaac-Renton J, Prystajecky NA, Tang P.

J Vis Exp. 2015 Apr 17;(98). doi: 10.3791/52685.

17.

Identification and regulation of a novel Citrobacter rodentium gut colonization fimbria (Gcf).

Caballero-Flores GG, Croxen MA, Martínez-Santos VI, Finlay BB, Puente JL.

J Bacteriol. 2015 Apr;197(8):1478-91. doi: 10.1128/JB.02486-14. Epub 2015 Feb 9.

18.

Autophagy facilitates Salmonella replication in HeLa cells.

Yu HB, Croxen MA, Marchiando AM, Ferreira RB, Cadwell K, Foster LJ, Finlay BB.

MBio. 2014 Mar 11;5(2):e00865-14. doi: 10.1128/mBio.00865-14.

19.

Recent advances in understanding enteric pathogenic Escherichia coli.

Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB.

Clin Microbiol Rev. 2013 Oct;26(4):822-80. doi: 10.1128/CMR.00022-13. Review.

20.

EscA is a crucial component of the type III secretion system of enteropathogenic Escherichia coli.

Sal-Man N, Biemans-Oldehinkel E, Sharon D, Croxen MA, Scholz R, Foster LJ, Finlay BB.

J Bacteriol. 2012 Jun;194(11):2819-28. doi: 10.1128/JB.00103-12. Epub 2012 Mar 23.

21.

The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b.

Shames SR, Croxen MA, Deng W, Finlay BB.

Infect Immun. 2011 Dec;79(12):4784-90. doi: 10.1128/IAI.05761-11. Epub 2011 Sep 26.

22.

The deubiquitinase activity of the Salmonella pathogenicity island 2 effector, SseL, prevents accumulation of cellular lipid droplets.

Arena ET, Auweter SD, Antunes LC, Vogl AW, Han J, Guttman JA, Croxen MA, Menendez A, Covey SD, Borchers CH, Finlay BB.

Infect Immun. 2011 Nov;79(11):4392-400. doi: 10.1128/IAI.05478-11. Epub 2011 Aug 29.

23.

The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300.

Shames SR, Bhavsar AP, Croxen MA, Law RJ, Mak SH, Deng W, Li Y, Bidshari R, de Hoog CL, Foster LJ, Finlay BB.

Cell Microbiol. 2011 Oct;13(10):1542-57. doi: 10.1111/j.1462-5822.2011.01640.x. Epub 2011 Aug 4.

PMID:
21812888
24.

Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.

Sham HP, Shames SR, Croxen MA, Ma C, Chan JM, Khan MA, Wickham ME, Deng W, Finlay BB, Vallance BA.

Infect Immun. 2011 Sep;79(9):3552-62. doi: 10.1128/IAI.05033-11. Epub 2011 Jul 11.

25.

The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization.

Ferreira RB, Gill N, Willing BP, Antunes LC, Russell SL, Croxen MA, Finlay BB.

PLoS One. 2011;6(5):e20338. doi: 10.1371/journal.pone.0020338. Epub 2011 May 25.

26.

Translocation of effectors: revisiting the injectosome model.

Sal-Man N, Croxen MA, Finlay BB.

Future Microbiol. 2011 May;6(5):483-4. doi: 10.2217/fmb.11.33. No abstract available.

28.

A comprehensive proteomic analysis of the type III secretome of Citrobacter rodentium.

Deng W, de Hoog CL, Yu HB, Li Y, Croxen MA, Thomas NA, Puente JL, Foster LJ, Finlay BB.

J Biol Chem. 2010 Feb 26;285(9):6790-800. doi: 10.1074/jbc.M109.086603. Epub 2009 Dec 24.

29.

Molecular mechanisms of Escherichia coli pathogenicity.

Croxen MA, Finlay BB.

Nat Rev Microbiol. 2010 Jan;8(1):26-38. doi: 10.1038/nrmicro2265. Review. Erratum in: Nat Rev Microbiol. 2013 Feb;11(2):141.

PMID:
19966814
30.
31.
32.

Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni.

Hoffman PS, Sisson G, Croxen MA, Welch K, Harman WD, Cremades N, Morash MG.

Antimicrob Agents Chemother. 2007 Mar;51(3):868-76. Epub 2006 Dec 11.

33.

Supplemental Content

Loading ...
Support Center